RENOVACARE
RenovaCare, Inc., formerly Janus Resources, Inc., is a biotechnology company. The Company is focused on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The Company's initial products under development target skin. The Company, through RenovaCare Sciences Corp., offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). It is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma.
RENOVACARE
Industry:
Biotechnology Medical Device Therapeutics
Founded:
1983-07-14
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.renovacareinc.com
Total Employee:
1+
Status:
Active
Contact:
888-398-0202
Email Addresses:
[email protected]
Total Funding:
17.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kalen Capital
Kalen Capital investment in Post-IPO Equity - RenovaCare
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-10 | RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services |
Official Site Inspections
http://www.renovacareinc.com Semrush global rank: 2.97 M Semrush visits lastest month: 5.48 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "RenovaCare"
RenovaCare
Our flagship technology, the CellMistâ„¢ System, uses our patented SkinGunâ„¢ to spray a liquid suspension of a patient’s stem cells - the CellMistâ„¢ Solution - onto wounds. RenovaCare, Inc. …See details»
General 1 — RenovaCare
Our flagship technology, the CellMistâ„¢ System, uses our patented SkinGunâ„¢ to spray a liquid suspension of a patient’s stem cells – the CellMistâ„¢ Solution – onto wounds. We’re also developing medical-grade liquid spray devices for wound. …See details»
RenovaCare - Crunchbase Company Profile & Funding
RenovaCare, Inc., formerly Janus Resources, Inc., is a biotechnology company. The Company is focused on the acquisition, research, development and commercialization of autologous …See details»
RenovaCare Announces Organizational Changes and Appointment …
Mar 30, 2021 · RenovaCare, Inc. is developing new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Announces Organizational Changes and Appointment …
Mar 30, 2021 · About RenovaCare RenovaCare, Inc. is developing new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial …See details»
RenovaCare, Inc. - LinkedIn
RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Our initial products...See details»
RenovaCare Announces Management Changes - GlobeNewswire
Mar 24, 2022 · RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Provides Clinical and Corporate Update
Mar 9, 2022 · RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Announces Termination of StemCell Systems R&D …
May 3, 2022 · RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Provides Clinical and Corporate Update
Mar 9, 2022 · RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under development targets the...See details»
Renovacare | VentureRadar
Website: http://www.renovacareinc.com. RenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human ...See details»
RenovaCare Establishes Leadership Position in Cell - GlobeNewswire
Oct 14, 2021 · RenovaCare, Inc. is developing new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Announces Organizational Changes and Appointment …
Mar 30, 2021 · RenovaCare, Inc. is developing new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
RenovaCare Announces Organizational Changes and Appointment …
ROSELAND, N.J., March 30, 2021 -- RenovaCare, Inc. , developer of patented technologies for spraying self-donated stem cells for the regeneration of organs and tissues, announced today …See details»
RenovaCare Provides Clinical and Corporate Update - BioSpace
Mar 9, 2022 · RenovaCare, Inc. is a developer of new generation autologous stem cell therapies for the regeneration of human organs and tissues. The Company’s initial product under …See details»
Thought Leadership & Innovation Foundation to Expand Its …
Oct 28, 2019 · RenovaCare, Inc. is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Initial …See details»
RenovaCare Chairman Discusses 2020 Highlights and Provides …
Dec 22, 2020 · RenovaCare 2021 Outlook RenovaCare Discusses 2020 Highlights and Provides 2021 Outlook RenovaCare Chairman & CEO, Alan L. Rubino Alan L. Rubino Chairman & CEO …See details»
RenovaCare Strengthens FDA Program with Leading U.S.
May 28, 2020 · RenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets …See details»
PRA statement in relation to the MiFID Org Reg | Bank of England
Nov 15, 2024 · The PRA’s statement on the FCA’s consultation on proposals to transfer the firm facing requirements of the Commission Delegated Regulation (EU) 2017/565 on …See details»
RenovaCare Strengthens FDA Program with Leading U.S.
ROSELAND, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for ...See details»